Trials / Completed
CompletedNCT02684500
Aneurysmal Subarachnoid Hemorrhage and Superior Mesenteric Artery Flow Study
Evaluation of Superior Mesenteric Artery Diameter and Flow in Aneurysmal Subarachnoid Hemorrhage Patients Undergoing Hypertensive Therapy for Cerebral Artery Vasospasm
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 14 (actual)
- Sponsor
- University of Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to determine if the diameter and flow of the superior mesenteric artery in patients with aneurysmal subarachnoid hemorrhage undergoing hypertensive therapy for cerebral artery vasospasm are effected enough to justify withholding enteral nutrition.
Detailed description
Study measurements of the diameter and Doppler flow velocity of the superior mesenteric artery (SMA) using abdominal ultrasound in order to evaluate the potential additional risk of non-occlusive mesenteric ischemia (NOMI) and non occlusive bowel necrosis (NOBN) in patients undergoing hypertensive therapy for cerebral vasospasm in Aneurysmal Subarachnoid Hemorrhage (aSAH), to justify the withholding of enteral nutrition.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Ultrasound | Study measurements of the diameter and doppler flow velocity of the superior mesenteric artery (SMA) for a aneurysmal subarachnoid hemorrhage using abdominal ultrasound. |
Timeline
- Start date
- 2016-04-11
- Primary completion
- 2016-06-30
- Completion
- 2016-06-30
- First posted
- 2016-02-18
- Last updated
- 2020-03-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02684500. Inclusion in this directory is not an endorsement.